| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.15B | +30.0% |
| Gross profit | ¥0.07B | — |
| Operating income | ¥0.03B | — |
| Net income | ¥0.03B | — |
| Gross margin | 44.4% | Net margin 17.4% |
| Revenue Q/Q | +32.5% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.09B | 55.6% |
| R&D | ¥0.01B | 4.4% |
| SG&A | ¥0.03B | 20.0% |
| Tax & other | ¥0.00B | 3.2% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
罗博特科 ・ 七彩化学 ・ 康龙化成 ・ 立华股份 ・ 上海瀚讯 ・ 锦浪科技 ・ 石药创新 ・ 每日互动 ・ 震安科技 ・ 迪普科技 ・ 德方纳米 ・ 新媒股份
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies